Two new groundbreaking obesity studies could change the future of treatments

Two groundbreaking Novo Nordisk studies — the STEP UP and REDEFINE 1 trials — are shedding light on the potential for even better weight loss results with higher dosing of the medications currently in use or through new medications that may hit the market soon.